8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 9, 2025 · 1y ago · Accession 0000950170-25-083799
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 1674416
- Form type
- 8-K
- Filing date
- Jun 9, 2025
- Report date
- Jun 5, 2025
- Document
- crsp-20250605.htm
- Size
- 1024 KB